Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Globus Medical, Inc. (NYSE: GMED).

Full DD Report for GMED

You must become a subscriber to view this report.


Recent News from (NYSE: GMED)

Credit Suisse sees 18% upside in Abbott in premarket analyst action
Abbott (NYSE: ABT ) initiated with Outperform rating and $82 (18% upside) price target at Credit Suisse. More news on: Abbott Laboratories, Alnylam Pharmaceuticals, Inc., Baxter International Inc, Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: December, 18 2018 08:05
Today's Research Reports on Trending Tickers: Edwards Lifesciences and Globus Medical
NEW YORK, NY / ACCESSWIRE / December 7, 2018 / U.S. equities finished modestly lower on Thursday as trade concerns were reignited after the arrest of a Huawei senior executive. The Dow Jones Industrial Average fell 0.32 percent to close at 24,947.67, while the S&P 500 Index decreased 0.1...
Source: ACCESSWIRE IA
Date: December, 07 2018 08:00
Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System
AUDUBON, Pa., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS®, a revolutionary robotic guidance and navigation system, to the international market with system installations...
Source: GlobeNewswire
Date: December, 06 2018 16:30
Bulletproof Investing Performance Update: Week 53
Safety first: NASCAR driver Johanna Long and her helmet (Photo via Autowise ) Bulletproof Investing: Week 53 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This i...
Source: SeekingAlpha
Date: December, 04 2018 13:12
Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics - New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aclaris Therapeutics, Inc. (NASDAQ:ACRS), Extreme Networks, Inc. (NASDAQ:...
Source: GlobeNewswire
Date: November, 27 2018 07:50
Notable earnings after Thursday's close
AGO , AL , ALTR , AMBR , AMC , AMPH , AQN , ARRS , ASRT , ATVI , BOJA , BPI , BRS , BW , CBPX , COLD , COLL , CTL , CYRX , DBX , DIS , DOX , ECOM , EGAN , EPAY , ERI , FGEN , FOE , FSCT , FSM , FTCH , GMED , HDP , HTZ , ICUI , JAG , JJSF , LGF.A , LOPE...
Source: SeekingAlpha
Date: November, 07 2018 17:35
Bulletproof Investing Performance Update: Week 48
Safety first: NASCAR driver Johanna Long and her helmet (via Autowise ) Bulletproof Investing: Week 48 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is an "...
Source: SeekingAlpha
Date: October, 28 2018 14:22
Bulletproof Investing Performance Update: Week 46
Safety first: NASCAR driver Johanna Long and her helmet (via Autowise ) Bulletproof Investing: Week 46 Performance Each week since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This is an "...
Source: SeekingAlpha
Date: October, 21 2018 22:58
Globus Medical Schedules Third Quarter 2018 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2018 after the market close on Thursday, November 8 th , 2018. A copy of the re...
Source: GlobeNewswire
Date: October, 19 2018 16:30
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association Annual Meeting October 17 th - 20 th in Orlando Florida. During the...
Source: GlobeNewswire
Date: October, 17 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1453.1053.0153.69552.63265,771
2017-02-0226.3125.9626.4225.95621,158
2017-02-0126.5126.3126.7326.20840,486
2017-01-3126.2526.3626.4025.93504,749
2017-01-3026.0226.2726.2925.71740,169

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-178,30415,53153.4673Short
2018-12-1415,44930,43550.7606Short
2018-12-131,7688,94219.7719Cover
2018-12-121,3866,22622.2615Cover
2018-12-111,5188,83917.1739Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GMED.


About Globus Medical, Inc. (NYSE: GMED)

Logo for Globus Medical, Inc. (NYSE: GMED)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $4,989,321,602 - 05/18/2018
  • Issue and Outstanding: 97,466,724 - 04/25/2018

 


Recent Filings from (NYSE: GMED)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 08 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: May, 30 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 26 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 22 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 22 2018

 

 


Daily Technical Chart for (NYSE: GMED)

Daily Technical Chart for (NYSE: GMED)


Stay tuned for daily updates and more on (NYSE: GMED)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: GMED)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GMED is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GMED and does not buy, sell, or trade any shares of GMED. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/